Literature DB >> 19513768

The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis.

S E Blair1, N N Cokcetin, E J Harry, D A Carter.   

Abstract

There is an urgent need for new, effective agents in topical wound care, and selected honeys show potential in this regard. Using a medical-grade honey, eight species of problematic wound pathogens, including those with high levels of innate or acquired antibiotic resistance, were killed by 4.0-14.8% honey, which is a concentration that can be maintained in the wound environment. Resistance to honey could not be induced under conditions that rapidly induced resistance to antibiotics. Escherichia coli macroarrays were used to determine the response of bacterial cells to a sub-lethal dose of honey. The pattern of gene expression differed to that reported for other antimicrobial agents, indicating that honey acts in a unique and multifactorial way; 78 (2%) genes were upregulated and 46 (1%) genes were downregulated more than two-fold upon exposure to the medical-grade honey. Most of the upregulated genes clustered into distinct functional regulatory groups, with many involved in stress responses, and the majority of downregulated genes encoded for products involved in protein synthesis. Taken together, these data indicate that honey is an effective topical antimicrobial agent that could help reduce some of the current pressures that are promoting antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19513768     DOI: 10.1007/s10096-009-0763-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  63 in total

1.  The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds.

Authors:  R A Cooper; P C Molan; K G Harding
Journal:  J Appl Microbiol       Date:  2002       Impact factor: 3.772

2.  Prediction of mechanisms of action of antibacterial compounds by gene expression profiling.

Authors:  Bernd Hutter; Christoph Schaab; Sebastian Albrecht; Matthias Borgmann; Nina A Brunner; Christoph Freiberg; Karl Ziegelbauer; Charles O Rock; Igor Ivanov; Hannes Loferer
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  Genome-wide transcriptional profiling of the Escherichia coli response to a proline-rich antimicrobial peptide.

Authors:  Linda Tomasinsig; Marco Scocchi; Romina Mettulio; Margherita Zanetti
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 4.  Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Authors:  David J Payne; Michael N Gwynn; David J Holmes; David L Pompliano
Journal:  Nat Rev Drug Discov       Date:  2006-12-08       Impact factor: 84.694

Review 5.  The world of subinhibitory antibiotic concentrations.

Authors:  Julian Davies; George B Spiegelman; Grace Yim
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

6.  Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.

Authors:  John Weigelt; Kamal Itani; Dennis Stevens; William Lau; Matthew Dryden; Charles Knirsch
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  Randomized clinical trial of honey-impregnated dressings for venous leg ulcers.

Authors:  Andrew Jull; N Walker; V Parag; P Molan; A Rodgers
Journal:  Br J Surg       Date:  2008-02       Impact factor: 6.939

Review 8.  Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.

Authors:  Rupali Jain; Larry H Danziger
Journal:  Ann Pharmacother       Date:  2004-07-27       Impact factor: 3.154

9.  Signal transduction cascade between EvgA/EvgS and PhoP/PhoQ two-component systems of Escherichia coli.

Authors:  Yoko Eguchi; Tadashi Okada; Shu Minagawa; Taku Oshima; Hirotada Mori; Kaneyoshi Yamamoto; Akira Ishihama; Ryutaro Utsumi
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

Review 10.  Bacterial production of methylglyoxal: a survival strategy or death by misadventure?

Authors:  I R Booth; G P Ferguson; S Miller; C Li; B Gunasekera; S Kinghorn
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

View more
  65 in total

1.  Multicentre prospective observational study on professional wound care using honey (Medihoney™).

Authors:  Bahram Biglari; Arash Moghaddam; Kai Santos; Gisela Blaser; Axel Büchler; Gisela Jansen; Alfred Längler; Norbert Graf; Ursula Weiler; Verena Licht; Anke Strölin; Brigitta Keck; Volker Lauf; Udo Bode; Tyler Swing; Ralph Hanano; Nicolas T Schwarz; Arne Simon
Journal:  Int Wound J       Date:  2012-04-11       Impact factor: 3.315

2.  The controlled in vitro susceptibility of gastrointestinal pathogens to the antibacterial effect of manuka honey.

Authors:  S M Lin; P C Molan; R T Cursons
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-17       Impact factor: 3.267

3.  Voluntary ingestion of antiparasitic drugs emulsified in honey represents an alternative to gavage in mice.

Authors:  Tatiana Küster; Beatrice Zumkehr; Corina Hermann; Regula Theurillat; Wolfgang Thormann; Bruno Gottstein; Andrew Hemphill
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

Review 4.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

Review 5.  Wound Dressings and Comparative Effectiveness Data.

Authors:  Aditya Sood; Mark S Granick; Nancy L Tomaselli
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-08-01       Impact factor: 4.730

Review 6.  Up-to-date use of honey for burns treatment.

Authors:  A Zbuchea
Journal:  Ann Burns Fire Disasters       Date:  2014-03-31

7.  In Vitro activity of Manuka Honey and polyhexamethylene biguanide on filamentous fungi and toxicity to human cell lines.

Authors:  Joseph M Yabes; Brian K White; Clinton K Murray; Carlos J Sanchez; Katrin Mende; Miriam L Beckius; Wendy C Zera; Joseph C Wenke; Kevin S Akers
Journal:  Med Mycol       Date:  2017-04-01       Impact factor: 4.076

8.  A Critical Review and Perspective of Honey in Tissue Engineering and Clinical Wound Healing.

Authors:  Katherine R Hixon; Robert C Klein; Christopher T Eberlin; Houston R Linder; William J Ona; Hugo Gonzalez; Scott A Sell
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-07-25       Impact factor: 4.730

9.  Manuka honey modulates the release profile of a dHL-60 neutrophil model under anti-inflammatory stimulation.

Authors:  Benjamin A Minden-Birkenmaier; Meghan B Meadows; Kasyap Cherukuri; Matthew P Smeltzer; Richard A Smith; Marko Z Radic; Gary L Bowlin
Journal:  J Tissue Viability       Date:  2020-03-26       Impact factor: 2.932

10.  The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.

Authors:  Lei Zhang; Sunil V Badve; Elaine M Pascoe; Elaine Beller; Alan Cass; Carolyn Clark; Janak de Zoysa; Nicole M Isbel; Steven McTaggart; Alicia T Morrish; E Geoffrey Playford; Anish Scaria; Paul Snelling; Liza A Vergara; Carmel M Hawley; David W Johnson
Journal:  Perit Dial Int       Date:  2015-07-29       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.